Calculate the total surface area of the human body, a key indicator for metabolic mass and clinical dosing.
BSA is often used in clinical settings over body weight because it is a more accurate indicator of metabolic mass and energy needs.
Body Surface Area (BSA) is the total surface area of the human body, calculated from your height and weight. It's not something you can measure with a tape – it's a mathematical estimate that has become one of the most widely used clinical tools in modern medicine.
Unlike BMI (which assesses weight relative to height) or simple body weight (which ignores frame size), BSA attempts to capture overall body size in a way that correlates with physiological functions like blood volume, cardiac output, and drug metabolism. That's why a "normal" adult BSA is generally taken as 1.73 m² – a reference value used to standardize everything from kidney function tests to chemotherapy doses.
Here's what most people miss: BSA wasn't developed for the average person. It was created to scale drug doses from animals to humans and from adults to children. A child with a BSA of 0.5 m² needs a proportionally smaller dose than a 1.73 m² adult – not based on weight alone, but on the complex relationship between body size, metabolism, and drug clearance. BSA calculators put this same mathematical precision into the hands of clinicians and patients alike.
Pro Tip: BSA is not a measure of health or fitness. A large athlete and a sedentary person of the same height and weight can have the same BSA. It's a scaling tool, not a diagnostic one.
Over a dozen formulas have been developed to estimate BSA. Each was derived from different populations and has its own strengths. The right formula depends on your patient population and clinical context.
The Mosteller formula is the simplest and most widely used in routine clinical practice. Its simplicity makes it ideal for quick calculations without a computer.
Example: A person who is 175 cm tall and weighs 72 kg:
The Mosteller method is recommended for routine clinical use due to its simplicity and accuracy.
Developed in 1916, this is the oldest and most extensively validated formula. It's the basis for many physiological reference values still used today.
This formula is considered the "original" BSA equation and remains widely used in research and clinical guidelines.
The Haycock formula was developed specifically to improve accuracy across a wider range of body sizes, including children and very tall individuals.
It is often preferred in pediatrics and for unusually tall patients.
The Boyd formula is considered the most accurate overall, particularly at the extremes of body size (very low or very high weight).
While more complex, it's the default choice in some clinical calculators when precision is paramount.
| Formula | Best For | Pros | Cons |
|---|---|---|---|
| Mosteller | Routine clinical use | Simplest, very good accuracy | Slightly less accurate at extremes |
| Du Bois | Historical reference, research | Most validated, widely cited | More complex calculation |
| Haycock | Pediatrics, tall adults | Better accuracy across size range | Less commonly used |
| Boyd | Extreme body sizes (very low/high weight) | Most accurate overall | Complex formula |
| Gehan & George | Research settings | Good alternative | Less clinical adoption |
The Calculator's Job: A good BSA calculator should offer multiple formulas (at least Mosteller, Du Bois, and Haycock), clearly label which is selected, and output results in square meters (m²). For clinical use, Mosteller is usually sufficient; for research or pediatrics, offering options is essential.
BSA isn't just an academic exercise – it's used daily in hospitals and clinics worldwide.
The doses of most anticancer drugs are scaled to body surface area rather than body weight. This approach evolved from the practice of using BSA to scale drug doses from animal models to humans and from adults to children.
Early studies demonstrated that BSA was a better predictor of drug toxicity than body weight alone, particularly for agents such as fluorouracil and methotrexate. In pediatric oncology, the Children's Oncology Group uses BSA to dose chemotherapeutics in children older than 3 years.
Why not just use weight? A 100 kg patient is not simply twice the size of a 50 kg patient in terms of drug distribution, metabolism, and elimination. BSA captures this allometric scaling more accurately.
Pro Tip: For infants with BSA <0.6 m², many protocols use "BSA banding" – pre‑calculated dose tables that gradually transition from weight‑based to BSA‑based dosing.
In cardiology, raw measurements like cardiac output (liters per minute) are divided by BSA to create the Cardiac Index (CI). This allows clinicians to compare heart function across patients of different sizes.
A normal CI ranges from 2.5 to 4.0 L/min/m². Without BSA, a large person would naturally have a higher cardiac output than a small person – BSA removes that size bias.
Glomerular filtration rate (GFR) – the gold standard measure of kidney function – is often normalized to BSA. A "normal" GFR of 90‑120 mL/min is actually 90‑120 mL/min per 1.73 m². That 1.73 m² is the reference BSA value against which all patients are compared.
Many drugs are dosed based on BSA, including:
The BSA constitutes a significant determinant for drug administration, with relevance extending toward the aspects of effectiveness and toxicity.
| Index | Formula | What It Measures |
|---|---|---|
| Stroke Volume Index | Stroke Volume ÷ BSA | Heart pumping efficiency |
| Left Ventricular Mass Index | LV Mass ÷ BSA | Heart muscle thickness |
| Renal Blood Flow Index | RBF ÷ BSA | Kidney perfusion |
BSA varies significantly by age, sex, and body size. There's no single "normal" – but there are reference values.
| Population | Average BSA |
|---|---|
| Adult men | 1.9 m² |
| Adult women | 1.6 m² |
| Child (9 years) | 1.07 m² |
| Child (2 years) | 0.5 m² |
| Neonate (newborn) | 0.25 m² |
Sources: LOINC, Bionity
The commonly cited "normal" BSA of 1.73 m² is a reference value used for standardizing physiologic measurements – not a target or ideal. For example, cardiac index is expressed as L/min/m², normalized to 1.73 m².
Pro Tip: If your BSA differs from 1.73 m², that doesn't indicate a health problem. It simply means your body size differs from the reference population used to create that standard.
BSA calculations may be inaccurate in overweight and obese children since they assume a uniform distribution of adipose tissue. In adults, dosing based on body weight or body surface area assumes that drug pharmacokinetic parameters increase in proportion with increasing body size – an assumption that may not hold in obesity.
In overweight and obese children, Z scores based on BSA have been shown to cause systematic biases. BSA may be overestimated in overweight individuals and underestimated in underweight subjects.
BSA treats all kilograms as equal. Muscle and fat have very different metabolic and volume characteristics, but BSA doesn't distinguish between them. A bodybuilder and an obese person of the same height and weight have the same BSA – but their drug distribution, cardiac output, and metabolic rates are vastly different.
Studies have shown that BSA is only one of many factors influencing drug metabolism, and interpatient variability often remains high despite dose adjustments. Some researchers question whether BSA‑based dosing is still optimal, particularly for newer targeted therapies and immunotherapies.
Pro Tip: For obese patients, many clinicians use ideal body weight (IBW) or adjusted body weight (ABW) instead of actual weight for BSA calculations, or use alternative dosing strategies altogether.
BSA is particularly important in children, where body size changes rapidly and drug toxicity risks are higher.
A 3‑month‑old infant with a BSA of 0.3 m² and body weight of 5.3 kg would receive a dramatically different chemotherapy dose if calculated by BSA versus body weight alone – a 40% difference. This is why pediatric oncology protocols carefully specify BSA‑based dosing with age‑appropriate adjustments.
For infants and children with a BSA <0.6 m², the Children's Oncology Group recommends a gradual transition from body weight‑based to BSA‑based dosing using pre‑calculated dose tables (BSA banding).
BSA calculations may still be inaccurate in overweight and obese children since they assume a uniform distribution of adipose tissue. Z scores based on BSA have been shown to cause systematic biases in overweight and obese children.
The Calculator's Job: A pediatric BSA calculator should include age‑appropriate formulas (Haycock, Boyd), output BSA in m², and ideally provide comparison to age‑based percentiles.
| BSA | BMI | |
|---|---|---|
| Formula | √(H × W / 3600) or similar | W (kg) ÷ H² (m) |
| Output | Square meters (m²) | kg/m² |
| What it measures | Total body surface area | Weight relative to height |
| Primary use | Drug dosing, physiologic indexing | Weight classification, population health |
| Sensitive to muscle mass? | No (same BSA for muscular and obese) | No (same BMI for muscular and obese) |
| Clinical applications | Chemotherapy, cardiology, renal function | Obesity screening, metabolic risk |
Key takeaway: Both are imperfect proxies for body composition. BSA is better for scaling drug doses and physiologic measurements; BMI is better for population‑level weight classification.
| Height | Weight | Mosteller BSA (m²) | Typical Context |
|---|---|---|---|
| 5'0" (152 cm) | 100 lbs (45 kg) | 1.38 | Small adult |
| 5'5" (165 cm) | 140 lbs (64 kg) | 1.73 | "Reference" adult |
| 5'10" (178 cm) | 170 lbs (77 kg) | 1.93 | Average adult man |
| 6'0" (183 cm) | 200 lbs (91 kg) | 2.10 | Larger adult |
| 6'4" (193 cm) | 240 lbs (109 kg) | 2.36 | Very large adult |
| Mistake | Why It's Wrong |
|---|---|
| Using BSA as a health or fitness metric | BSA is a scaling tool, not a measure of health. A high BSA doesn't mean you're unhealthy – it may just mean you're tall. |
| Assuming all formulas give the same result | Different formulas can differ by 0.05‑0.1 m² – enough to matter for chemotherapy dosing. Always know which formula your institution uses. |
| Using BSA in obesity without adjustment | BSA may overestimate body size in obese individuals, leading to excessive drug doses. Consider alternative dosing strategies. |
| Applying adult formulas to children | Adult formulas (Du Bois, Mosteller) were not validated in children. Use pediatric‑specific formulas like Haycock or Boyd. |
| Ignoring the 1.73 m² reference | When a test result says "normal 80‑120 mL/min/1.73 m²," that "per 1.73 m²" means it's already adjusted for BSA. Don't adjust it again. |
Scenario 1: Routine clinical use (chemotherapy, medication dosing)
→ Use the Mosteller formula – it's simple, widely accepted, and accurate enough for most clinical contexts.
Scenario 2: Pediatric patient or very tall adult
→ Use the Haycock formula, which was developed to improve accuracy across a wider range of body sizes.
Scenario 3: Research or extreme body size (very low or high weight)
→ Use the Boyd formula, which is considered the most accurate, especially at the extremes.
Then ask:
- Are you using the correct formula for your patient population?
- Is the patient obese? Consider using ideal or adjusted body weight instead of actual weight.
- Is this for drug dosing? Check the protocol – some drugs require specific formulas.
A BSA calculator is an essential clinical tool that turns height and weight into a number used daily in chemotherapy dosing, cardiac assessment, renal function evaluation, and burn management. The Mosteller formula is the best choice for most routine applications – it's simple, accurate, and widely accepted. For pediatrics, tall patients, or extreme body sizes, consider Haycock or Boyd instead.
Use a BSA calculator to:
Don't use a BSA calculator to:
The best BSA calculator is the one that gives you the right answer for your clinical context – and reminds you that this is an estimate, not a perfect measure. Use it with confidence, but always within its limits.
Sources: Du Bois D & Du Bois EF (1916), Mosteller RD (1987), Haycock GB et al. (1978), Boyd E (1935), Gehan EA & George SL (1970), National Cancer Institute, Children's Oncology Group
Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice. BSA-based dosing should always be performed by qualified healthcare professionals using institutionally approved protocols and formulas.
Explore more tools in the Other category